Aurora Cannabis announced its financial and operational results for Q1 2026. Total net revenue was $98 million, as compared ...

Shares of cannabis company Tilray Brands (NASDAQ:TLRY) jumped 4.9% in the afternoon session after the company announced the ...

Tilray cultivates and sells cannabis in Canada and exports into the global medical market. It also sells CBD and alcohol. The company is the result of legacy Aphria acquiring legacy Tilray in a ...

Seeking Alpha analysts highlight how shifts in market conditions and company-specific strategies lead to upgrades or downgrades in ratings for companies including WESCO International (WCC) and Tilray ...

Count yourself lucky if you haven't been a Tilray shareholder over the past five years. It's nice that Tilray is diversified, ...

Tilray Brands is down a lot in 2025 and since its IPO, but it has rallied substantially from its April all-time low. Read why ...

USA News Group News Commentary – What we consume and how we consume it continues to change, as the latest consumer products trends have been evolving over the last year. Dubbed ...

As the marijuana market grows more competitive, some retailers are shifting how they present their products to customers. These changes, going beyon ...

Roth Capital Markets analyst Bill Kirk maintained a “Neutral” rating and lowered his 12-month price target to $0.60 from $0.65.

Detailed price information for Tilray Brands Inc (TLRY-Q) from The Globe and Mail including charting and trades.

Detailed price information for Tilray Brands Inc (TLRY-Q) from The Globe and Mail including charting and trades.

Tilray Brands (TLRY) stock tumbles after Q4 2025 revenue miss; its cannabis rivals including Canopy (CGC), Aurora Cannabis ...